• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原在血小板表面的结合与激活。

Binding and activation of plasminogen on the platelet surface.

作者信息

Miles L A, Plow E F

出版信息

J Biol Chem. 1985 Apr 10;260(7):4303-11.

PMID:3920216
Abstract

A mechanism by which platelets might participate in fibrinolysis by binding plasminogen and influencing its activation has been examined. Binding of radioiodinated human Glu-plasminogen to washed human platelets was time-dependent and was enhanced 3-9-fold by stimulation of platelets with thrombin but not with ADP. The interaction with both stimulated and unstimulated cells was specific, saturable, divalent ion-independent, and reversible. The platelet-bound ligand had the molecular weight of plasminogen, and no conversion to plasmin was detected. Scatchard analyses provided evidence for a single class of plasminogen-binding sites on both stimulated and unstimulated cells. The Kd for thrombin-stimulated platelets was 2.6 +/- 1.3 microM, and 190,000 +/- 45,000 molecules were bound per cell, whereas unstimulated platelets bound 37,000 +/- 10,500 molecules/cell with a Kd of 1.9 +/- 0.15 microM. Plasminogen binding was inhibited in a dose-dependent manner by omega-aminocarboxylic acids at concentrations consistent with a requirement for an unoccupied high affinity lysine-binding site for plasminogen binding to the cells. When platelet-bound plasminogen was incubated with tissue plasminogen activator, urokinase, or streptokinase, gel analysis established that plasmin was preferentially associated with the platelet relative to the supernatant. Plasminogen and plasmin interacted with thrombin-stimulated platelets with similar binding characteristics, and there was no evidence for a binding site for plasmin which did not also bind plasminogen. Therefore, the results suggest that plasminogen activation is enhanced on the cell surface. In sum, these results indicate that platelets bind plasminogen at physiologic zymogen concentrations and this interaction may serve to localize and promote plasminogen activation.

摘要

已对血小板可能通过结合纤溶酶原并影响其激活来参与纤维蛋白溶解的机制进行了研究。放射性碘化人谷氨酸纤溶酶原与洗涤后的人血小板的结合具有时间依赖性,用凝血酶刺激血小板可使其增强3至9倍,但用ADP刺激则无此效果。与刺激和未刺激细胞的相互作用都是特异性的、可饱和的、不依赖二价离子的且可逆的。血小板结合的配体具有纤溶酶原的分子量,未检测到其转化为纤溶酶。Scatchard分析为刺激和未刺激细胞上存在单一类别的纤溶酶原结合位点提供了证据。凝血酶刺激的血小板的解离常数(Kd)为2.6±1.3微摩尔,每个细胞结合190,000±45,000个分子,而未刺激的血小板每个细胞结合37,000±10,500个分子,Kd为1.9±0.15微摩尔。ω-氨基羧酸以剂量依赖性方式抑制纤溶酶原结合,其浓度与纤溶酶原结合细胞需要一个未被占据的高亲和力赖氨酸结合位点一致。当将血小板结合的纤溶酶原与组织纤溶酶原激活剂、尿激酶或链激酶一起孵育时,凝胶分析表明,相对于上清液,纤溶酶优先与血小板相关。纤溶酶原和纤溶酶与凝血酶刺激的血小板相互作用具有相似的结合特性,没有证据表明存在不结合纤溶酶原的纤溶酶结合位点。因此,结果表明纤溶酶原激活在细胞表面增强。总之,这些结果表明血小板在生理酶原浓度下结合纤溶酶原,这种相互作用可能有助于定位和促进纤溶酶原激活。

相似文献

1
Binding and activation of plasminogen on the platelet surface.纤溶酶原在血小板表面的结合与激活。
J Biol Chem. 1985 Apr 10;260(7):4303-11.
2
Plasminogen interaction with platelets: the importance of carboxyterminal lysines.纤溶酶原与血小板的相互作用:羧基末端赖氨酸的重要性。
Thromb Res. 2005;116(6):499-507. doi: 10.1016/j.thromres.2005.03.021.
3
Characterization of the binding of human tissue-type plasminogen activator to platelets.人组织型纤溶酶原激活剂与血小板结合的特性研究
J Biol Chem. 1989 Sep 25;264(27):15869-74.
4
Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator.凝血酶刺激血小板可诱导由内源性尿激酶型纤溶酶原激活物介导的纤溶酶原激活。
Blood. 1997 Nov 1;90(9):3579-86.
5
Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.组织型纤溶酶原激活物对正常血小板和血小板无力症血小板纤溶酶原的激活作用:对表面蛋白和血小板聚集的影响
Blood. 1986 Jul;68(1):275-80.
6
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.纤溶酶原系统与细胞表面:同一细胞类型上存在纤溶酶原和尿激酶受体的证据。
J Cell Biol. 1986 Dec;103(6 Pt 1):2411-20. doi: 10.1083/jcb.103.6.2411.
7
Plasminogen interacts with human platelets through two distinct mechanisms.纤溶酶原通过两种不同机制与人血小板相互作用。
J Clin Invest. 1986 Jun;77(6):2001-9. doi: 10.1172/JCI112529.
8
Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator.组织型纤溶酶原激活剂激活血小板表面纤溶酶原的动力学及机制
Biochemistry. 1994 Mar 15;33(10):2970-6. doi: 10.1021/bi00176a029.
9
The cell-binding domains of plasminogen and their function in plasma.纤溶酶原的细胞结合结构域及其在血浆中的功能。
J Biol Chem. 1988 Aug 25;263(24):11928-34.
10
Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes.血小板膜中一种新型尿激酶型纤溶酶原激活剂结合蛋白的证据。
Blood. 1996 Apr 1;87(7):2775-81.

引用本文的文献

1
Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease.纤溶酶原错义变体及其与心血管和炎症性疾病的关联。
Front Cardiovasc Med. 2024 Jun 25;11:1406953. doi: 10.3389/fcvm.2024.1406953. eCollection 2024.
2
All tangled up: interactions of the fibrinolytic and innate immune systems.错综复杂:纤维蛋白溶解系统与先天免疫系统的相互作用。
Front Med (Lausanne). 2023 Jun 2;10:1212201. doi: 10.3389/fmed.2023.1212201. eCollection 2023.
3
Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis.
区分纤溶酶原生成的微囊泡:参与纤溶和蛋白水解的微小信使。
Int J Mol Sci. 2023 Jan 13;24(2):1571. doi: 10.3390/ijms24021571.
4
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk.致动脉粥样硬化脂蛋白与他汀类药物残余心血管疾病风险。
Int J Mol Sci. 2022 Nov 4;23(21):13499. doi: 10.3390/ijms232113499.
5
The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.嗜铬粒蛋白 A 衍生肽胰淀素的免疫调节功能。
Peptides. 2022 Dec;158:170893. doi: 10.1016/j.peptides.2022.170893. Epub 2022 Oct 13.
6
Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.纤溶酶原激活系统在血小板病理生理学中的作用:转化应用的新观点。
Int J Mol Sci. 2022 May 28;23(11):6065. doi: 10.3390/ijms23116065.
7
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.尿激酶型纤溶酶原激活系统在胰腺癌中的作用:有前景的诊断和治疗靶点。
Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152.
8
Metal Ions Bound to Prion Protein Affect its Interaction with Plasminogen Activation System.金属离子与朊病毒蛋白结合会影响其与纤溶酶原激活系统的相互作用。
Protein J. 2022 Feb;41(1):88-96. doi: 10.1007/s10930-021-10035-4. Epub 2022 Jan 17.
9
The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.膜联蛋白 A2/钙结合蛋白 S100A10 复合物对致癌性纤溶酶原受体的调控作用。
Biomolecules. 2021 Nov 26;11(12):1772. doi: 10.3390/biom11121772.
10
Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity.脂蛋白(a)与内在和氯吡格雷抵抗的血小板反应之间的关系。
J Thromb Thrombolysis. 2022 Jan;53(1):1-9. doi: 10.1007/s11239-021-02515-2. Epub 2021 Jul 2.